Effect of Teriflunomide on Cells From Patients With Human T-cell Lymphotropic Virus Type 1-Associated Neurologic Disease. [PDF]
Enose-Akahata Y +6 more
europepmc +1 more source
Case Report: Atypical Cutaneous Presentation of Human T-cell Lymphotropic Virus Type 1-Related Adult T-cell Lymphoma. [PDF]
Avallone G +11 more
europepmc +1 more source
Rational design of chimeric Multiepitope Based Vaccine (MEBV) against human T-cell lymphotropic virus type 1: An integrated vaccine informatics and molecular docking based approach. [PDF]
Tariq MH +6 more
europepmc +1 more source
Human T Cell Lymphotropic Virus Type II and Human Immunodeficiency Virus Type 1 Disease Progression [PDF]
Lee H. Harrison, Mauro Schechter
openaire +2 more sources
Response to: RSBMT-2018-0270.R2 - Pain and quality of life in human T cell lymphotropic virus type 1 associated myelopathy or tropical spastic paraparesis after home-based exercise protocol: Randomized clinical trial. [PDF]
Macêdo MC +5 more
europepmc +1 more source
Mother-to-child Transmission of Human T-cell Lymphotropic Virus Type 1
Hiroyuki, Moriuchi +3 more
openaire +2 more sources
[Human T-cell lymphotropic virus type 1(HTLV-1)-associated myelopathy].
HTLV-1-associated myelopathy (HAM), also known as tropical spastic paraparesis (TSP), is a chronic progressive demyelinating disease that affects the spinal cord and white matter of the central nervous system. The lifetime incidence of HAM in HTLV-1 carriers is estimated to be less than 5%.
João Gabriel Ramos, Ribas +1 more
openaire +1 more source
Human T-cell lymphotropic virus type 1 transmission dynamics in rural villages in the Democratic Republic of the Congo with high nonhuman primate exposure. [PDF]
Halbrook M +9 more
europepmc +1 more source
Molecular detection of human T cell lymphotropic virus type 1 in pregnant women from Maranhão state, Brazil. [PDF]
de Fátima Castro Mendes M +8 more
europepmc +1 more source
Dolutegravir Reduces Human T-Cell Lymphotropic Virus Type 1 Proviral Load and Improves Neurological Outcomes in a Phase 2 Controlled Trial. [PDF]
Brites C +8 more
europepmc +1 more source

